---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-001003"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2025-06-25T23:59:59+00:00"
generated_at: "2026-05-18T19:08:42.016618+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lipella Pharmaceuticals Delisted from Nasdaq, Plans to Relist on National Exchange

## Summary
- Delisted from Nasdaq effective June 19, 2025 due to non-compliance with Listing Rules 5100, 5635, and 5640 regarding private placement transactions.
- Common stock now quoted on OTC Pink Market under symbol LIPO; company remains fully reporting with SEC.
- CEO Jonathan Kaufman issued stockholder letter detailing plans to submit initial listing application to another national exchange.
- Clinical programs LP-310 (oral lichen planus) and LP-10 (hemorrhagic cystitis) continue unaffected; final LP-310 Phase 2a data expected H2 2025.
- Company states delisting was not due to financial instability and maintains sufficient capital for development programs.

## SEC filing metadata
- accession: 0001753926-25-001003
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2025-06-25T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392625001003/0001753926-25-001003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392625001003/g084855_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-001003
- JSON: https://secwatch.observer/filing/0001753926-25-001003.json
- Plain text: https://secwatch.observer/filing/0001753926-25-001003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.